PAG
DNTH icon

Private Advisor Group’s Dianthus Therapeutics DNTH Stock Holding History

Private Advisor Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Buy
+5,386
New +$470K ﹤0.01% 1767

Other funds holding DNTH

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Private Advisor Group's DNTH Position: Q2 2026 in Review

Private Advisor Group opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 5,386 shares worth $525K. The stake represents ﹤0.01% of the portfolio and ranks #1767 among its holdings.

25 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Private Advisor Group held 5,386 shares of Dianthus Therapeutics worth $525K as of Q2 2026.
  • Dianthus Therapeutics was a new Private Advisor Group position in Q2 2026.
  • Dianthus Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1767 holding.
  • 25 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.